Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma

Por Juncheng Cui, Dylan Dean, Francis J Hornicek, Guoliang Yi, Zhenfeng Duan
Publicado em 2022-05-01

CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

Por Tang Liu, Zuyun Yan, Yong Liu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan
Publicado em 2018-04-01

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

Por Wenlong Feng, Dylan C. Dean, Francis J. Hornicek, Dimitrios Spentzos, Robert M. Hoffman, Huirong Shi, Zhenfeng Duan
Publicado em 2020-05-01

Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma

Por Xiaoyang Li, Dylan C. Dean, Jin Yuan, Thomas H. Temple, Jonathan C. Trent, Andrew E. Rosenberg, Shengji Yu, Francis J. Hornicek, Zhenfeng Duan
Publicado em 2022-05-01